IBB
Equity
iShares Biotechnology ETF
- NAV as ofOct 23, 2026
- $207.7252 WK: 154.57 - 216.92
- 1 Day NAV Change as ofOct 23, 2026
- Decrease $
-1.91(-0.91%)
- NAV Total Return as ofOct 22, 2026
- YTD: Increase
24.31%
- 30 Day SEC Yield as ofSep 30, 2026
- -0.15%
- 12m Trailing Yield as ofSep 30, 2026
- 0.16%
- Expense Ratio:Fees as stated in the prospectus
- 0.44%
- Morningstar Rating
- 3 stars
- Morningstar Medalist Rating
- NAV as ofOct 23, 2026
- $207.7252 WK: 154.57 - 216.92
- 1 Day NAV Change as ofOct 23, 2026
- Decrease $
-1.91(-0.91%)
- NAV Total Return as ofOct 22, 2026
- YTD: Increase
24.31%
- 30 Day SEC Yield as ofSep 30, 2026
- -0.15%
- 12m Trailing Yield as ofSep 30, 2026
- 0.16%
- Expense Ratio:Fees as stated in the prospectus
- 0.44%
- Morningstar Rating
- 3 stars
- Morningstar Medalist Rating
The iShares Biotechnology ETF seeks to track an index that includes U.S.-listed equities in the biotechnology sector. The fund offers a way to express a focused view on companies engaged in the research and development of therapeutic treatments.
Key Facts
Net Assets of Fund
Closing Price
Daily Volume
Exchange
NASDAQ
Benchmark Index
NYSE Biotechnology Index
Investment Style
Index
Distribution Frequency
Quarterly
CUSIP
464287556
30 Day Avg. Volume
1,658,334.00
as of Oct 23, 2026
Fund Launch Date
Feb 05, 2001
Asset Class
Equity
Bloomberg Index Ticker
ICEBIOT
Shares Outstanding
51,650,000
as of Oct 23, 2026
Premium/Discount